Radical cystectomy: the minimally invasive approach

Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer: a phase 3, multicentre, randomised, double-blind, placebo-controlled trial.

The Lancet. Oncology·2026

The Future Is Bright for Women in Urologic Oncology: Trends over Two Decades.

Cancers·2026

Diagnostic performance of Cxbladder Triage Plus for the identification and stratification of patients at risk for urothelial carcinoma: The multicenter, prospective, observational DRIVE study.

Urologic oncology·2025

Unveiling Racial Disparities in Localized Prostate Cancer: A Systems-Level Exploration of the lncRNA Landscape.

Genes·2025

ACR Appropriateness Criteria® Acute Onset Flank Pain-Suspicion of Stone Disease (Urolithiasis).

Journal of the American College of Radiology : JACR·2023

ACR Appropriateness Criteria® Acute Pyelonephritis: 2022 Update.

Journal of the American College of Radiology : JACR·2022

Defining a hilar "danger zone" to guide surgical decision-making in T1 renal cell carcinoma.

Urologic oncology·2026

Biopsy Gleason pattern 4 burden refines preoperative risk stratification in prostate cancer.

Urologic oncology·2026

Impact of divergent differentiation and histological subtypes on oncologic outcomes in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma.

Urologic oncology·2026

Use of pelvic lymph node dissection among men undergoing radical prostatectomy in the US: Population-based analysis between 2010 and 2020.

Urologic oncology·2026

Second primary cancer risk after penile squamous cell carcinoma: A population-based study.

Urologic oncology·2026

Expanding indications for PARP inhibitors in prostate cancer.

Urologic oncology·2026

Analysis of real-world clinical outcomes of perioperative chemotherapy compared to preoperative chemoradiotherapy in esophagogastric adenocarcinoma.

Cancer·2026

RETRACTION: USP44 Suppresses Proliferation and Enhances Apoptosis in Colorectal Cancer Cells by Inactivating the Wnt/β-catenin Pathway via Axin1 Deubiquitination.

Cell biology international·2026

First-line sugemalimab plus chemotherapy for metastatic non-small-cell lung cancer: an updated cost-effectiveness analysis based on 4-year survival data.

Expert review of pharmacoeconomics & outcomes research·2026

Survival Benefit of ARSI Therapy in Japanese mCSPC: A Systematic Review and Meta-Analysis.

International journal of urology : official journal of the Japanese Urological Association·2026

Patterns of radiological response to procarbazine and CCNU polychemotherapy in patients with oligodendroglioma.

Neuro-oncology advances·2026

Durable Complete Response Following Nivolumab Discontinuation in Human Papillomavirus (HPV)-Positive Oropharyngeal Carcinoma Complicated by Bullous Pemphigoid: A Case Report.

Cureus·2026

Related Experiment Videos

Radical cystectomy: the minimally invasive approach

Related Concept Videos

Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer: a phase 3, multicentre, randomised, double-blind, placebo-controlled trial.

The Future Is Bright for Women in Urologic Oncology: Trends over Two Decades.

Diagnostic performance of Cxbladder Triage Plus for the identification and stratification of patients at risk for urothelial carcinoma: The multicenter, prospective, observational DRIVE study.

Unveiling Racial Disparities in Localized Prostate Cancer: A Systems-Level Exploration of the lncRNA Landscape.

ACR Appropriateness Criteria® Acute Onset Flank Pain-Suspicion of Stone Disease (Urolithiasis).

ACR Appropriateness Criteria® Acute Pyelonephritis: 2022 Update.

Defining a hilar "danger zone" to guide surgical decision-making in T1 renal cell carcinoma.

Biopsy Gleason pattern 4 burden refines preoperative risk stratification in prostate cancer.

Impact of divergent differentiation and histological subtypes on oncologic outcomes in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma.

Use of pelvic lymph node dissection among men undergoing radical prostatectomy in the US: Population-based analysis between 2010 and 2020.

Second primary cancer risk after penile squamous cell carcinoma: A population-based study.

Expanding indications for PARP inhibitors in prostate cancer.

Analysis of real-world clinical outcomes of perioperative chemotherapy compared to preoperative chemoradiotherapy in esophagogastric adenocarcinoma.

RETRACTION: USP44 Suppresses Proliferation and Enhances Apoptosis in Colorectal Cancer Cells by Inactivating the Wnt/β-catenin Pathway via Axin1 Deubiquitination.

First-line sugemalimab plus chemotherapy for metastatic non-small-cell lung cancer: an updated cost-effectiveness analysis based on 4-year survival data.

Survival Benefit of ARSI Therapy in Japanese mCSPC: A Systematic Review and Meta-Analysis.

Patterns of radiological response to procarbazine and CCNU polychemotherapy in patients with oligodendroglioma.

Durable Complete Response Following Nivolumab Discontinuation in Human Papillomavirus (HPV)-Positive Oropharyngeal Carcinoma Complicated by Bullous Pemphigoid: A Case Report.

Related Experiment Videos

Radical cystectomy: the minimally invasive approach

Related Concept Videos

Related Articles